All Posts

Europe does not have one psychedelic law. This guide compares Portugal’s decriminalization model, the Netherlands’ mushroom and truffle distinction, and Switzerland’s exceptional medical and research licensing system.

Iboga is a Central African plant with deep traditional significance; ibogaine is one of its best-known alkaloids. This article reviews addiction and mental-health research, serious cardiac risks, and legal approaches in Canada, the United States, New Zealand and Brazil.

A current global guide to the difference between legalization, decriminalization, medical access and research access for psilocybin, LSD and MDMA, with examples from Australia, Switzerland, Portugal, the Netherlands, Canada and Brazil.

Ayahuasca is not simply another name for DMT. This article explains the traditional Amazonian preparation, its pharmacology, emerging mental-health research, major safety concerns and the very different legal approaches in Brazil, Peru and other countries.

A current, evidence-informed overview of Canadian law on psilocybin mushrooms, LSD and MDMA, including the federal CDSA, British Columbia’s expired decriminalization pilot, Alberta’s psychedelic-treatment licensing framework, and legal clinical-access pathways.

Why Professional Support, Screening, and Integration Matter Psilocybin has become one of the most discussed substances in modern mental-health research. Clinical studies have investigated its potential role in depression, treatment-resistant depression, anxiety, addiction, and existential distress. The early findings are important and, in some areas, promising. But there is a major misunderstanding developing alongside this interest: Evidence that psilocybin may be helpful in

Long before modern psychedelic research, psilocybin-containing mushrooms were used within distinct Mesoamerican ceremonial and healing traditions. This article explores documented Mazatec and other Indigenous contexts with cultural care and scientific accuracy.

During my university studies, and through the research work and literature reviews I was involved in, I repeatedly came across the growing scientific interest in psychedelics and their possible role in mental health. One name that appeared frequently outside academic literature was Golden Teacher. It is one of the best-known cultivated varieties commonly described as Psilocybe cubensis. But as I looked more closely at the research, an important distinction became clear: Scien

LSD: From Scientific Discovery to Prohibition — and Its Return to Mental Health Research LSD is often associated with the counterculture of the 1960s, but its story actually began in a pharmaceutical laboratory. Long before it became a symbol of recreational drug use, scientists were studying LSD as a possible tool for understanding the human mind and assisting psychotherapy. Today, after decades of limited research, LSD and other psychedelics are again being investigated in